These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24747515)

  • 1. Polymerase I and transcript release factor acts as an essential modulator of glioblastoma chemoresistance.
    Wang X; Liu T; Bai Y; Liao H; Qiu S; Chang Z; Liu Y; Yan X; Guo H
    PLoS One; 2014; 9(4):e93439. PubMed ID: 24747515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma.
    Yi K; Cui X; Liu X; Wang Y; Zhao J; Yang S; Xu C; Yang E; Xiao M; Hong B; Fang C; Kang C; Tan Y; Wang Q
    Front Immunol; 2021; 12():802795. PubMed ID: 35069587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTRF/cavin-1 is essential for multidrug resistance in cancer cells.
    Yi JS; Mun DG; Lee H; Park JS; Lee JW; Lee JS; Kim SJ; Cho BR; Lee SW; Ko YG
    J Proteome Res; 2013 Feb; 12(2):605-14. PubMed ID: 23214712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-à-go-go (EAG1).
    Bai Y; Liao H; Liu T; Zeng X; Xiao F; Luo L; Guo H; Guo L
    Eur J Cancer; 2013 Feb; 49(3):710-24. PubMed ID: 22999387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma.
    Yang E; Wang L; Jin W; Liu X; Wang Q; Wu Y; Tan Y; Wang Y; Cui X; Zhao J; Tong F; Hong B; Xiao M; Liu X; Fang C; Kang C
    Theranostics; 2022; 12(9):4330-4347. PubMed ID: 35673568
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.
    Huang K; Fang C; Yi K; Liu X; Qi H; Tan Y; Zhou J; Li Y; Liu M; Zhang Y; Yang J; Zhang J; Li M; Kang C
    Theranostics; 2018; 8(6):1540-1557. PubMed ID: 29556340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of the invasive potential of glioblastoma and expression of caveola-forming proteins caveolin-1 and CAVIN1.
    Pu W; Nassar ZD; Khabbazi S; Xie N; McMahon KA; Parton RG; Riggins GJ; Harris JM; Parat MO
    J Neurooncol; 2019 Jun; 143(2):207-220. PubMed ID: 30949900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways.
    Inder KL; Zheng YZ; Davis MJ; Moon H; Loo D; Nguyen H; Clements JA; Parton RG; Foster LJ; Hill MM
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.012245. PubMed ID: 22030351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2.
    Yi K; Zhan Q; Wang Q; Tan Y; Fang C; Wang Y; Zhou J; Yang C; Li Y; Kang C
    Neuro Oncol; 2021 Mar; 23(3):387-399. PubMed ID: 33140095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines.
    Sooman L; Ekman S; Andersson C; Kultima HG; Isaksson A; Johansson F; Bergqvist M; Blomquist E; Lennartsson J; Gullbo J
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):329-40. PubMed ID: 23736154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: role of matrix metalloprotease 9.
    Aung CS; Hill MM; Bastiani M; Parton RG; Parat MO
    Eur J Cell Biol; 2011; 90(2-3):136-42. PubMed ID: 20732728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in caveolae, caveolin, and polymerase 1 and transcript release factor (PTRF) expression in prostate cancer progression.
    Gould ML; Williams G; Nicholson HD
    Prostate; 2010 Nov; 70(15):1609-21. PubMed ID: 20564315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2-HO-1 Axis.
    Chuang HY; Hsu LY; Pan CM; Pikatan NW; Yadav VK; Fong IH; Chen CH; Yeh CT; Chiu SC
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells.
    Dong Y; Han Q; Zou Y; Deng Z; Lu X; Wang X; Zhang W; Jin H; Su J; Jiang T; Ren H
    Mol Cell Biochem; 2012 Nov; 370(1-2):89-102. PubMed ID: 22829019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis.
    Nassar ZD; Moon H; Duong T; Neo L; Hill MM; Francois M; Parton RG; Parat MO
    Oncotarget; 2013 Oct; 4(10):1844-55. PubMed ID: 24123650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of PDCD4 contributes to enhanced chemoresistance in Glioblastoma multiforme through de-repression of Bcl-xL translation.
    Liwak U; Jordan LE; Von-Holt SD; Singh P; Hanson JE; Lorimer IA; Roncaroli F; Holcik M
    Oncotarget; 2013 Sep; 4(9):1365-72. PubMed ID: 23965755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.
    Gal H; Pandi G; Kanner AA; Ram Z; Lithwick-Yanai G; Amariglio N; Rechavi G; Givol D
    Biochem Biophys Res Commun; 2008 Nov; 376(1):86-90. PubMed ID: 18765229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cellular senescence by the essential caveolar component PTRF/Cavin-1.
    Bai L; Deng X; Li J; Wang M; Li Q; An W; A D; Cong YS
    Cell Res; 2011 Jul; 21(7):1088-101. PubMed ID: 21445100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
    Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
    Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.